Skip to main content
Top
Published in: Abdominal Radiology 3/2009

01-06-2009

Endovascular management of aorto-iliac occlusive disease

Author: Gerard J. O’Sullivan

Published in: Abdominal Radiology | Issue 3/2009

Login to get access

Abstract

As the techniques for endovascular treatment of aortic bifurcation disease become more widely known, it is not enough for interventional radiologists (IR) to be merely technically excellent at the procedural aspects of this important intervention. They must also become expert at managing the patient, and establishing direct contact not only with the patient, but also with the patient’s primary doctor, usually their general practitioner. Younger IR physicians may have not had the opportunity to perform as many arterial catheter studies as their grayer counterparts for two main reasons: the shift towards non-invasive studies (US/CTA/MRA), and the encroachment of other specialties on the endovascular field of play. This is not a cause for despair. If you offer the best service, with the best results, you will, in time, get the referrals. However, you must be prepared to offer more than a glorified angiography service: critical to this is the establishment of an Interventional Radiology Clinic, as this then becomes the target for referrals from a variety of other specialties.
Literature
1.
go back to reference Interventional Radiology Setting Up and Running an Office-Based Clinical Practice Society of Interventional Radiology 2005 Interventional Radiology Setting Up and Running an Office-Based Clinical Practice Society of Interventional Radiology 2005
2.
go back to reference Norgen L, Hiatt WR, Dormandy JA et al (2007) Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26(2):81–157 Norgen L, Hiatt WR, Dormandy JA et al (2007) Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26(2):81–157
3.
go back to reference Pedrini L (2007) Considerations about TASC II: is it a suitable document for specialists? Eur J Vasc Endovasc Surg 34(4):411–414; author reply 415. Epub 2007 Jun 25 Pedrini L (2007) Considerations about TASC II: is it a suitable document for specialists? Eur J Vasc Endovasc Surg 34(4):411–414; author reply 415. Epub 2007 Jun 25
4.
go back to reference RESILIENT Trial (2007) One year data presented at TCT Washington. Lifestent nitinol stent v balloon angioplasty in superficial femoral arteries RESILIENT Trial (2007) One year data presented at TCT Washington. Lifestent nitinol stent v balloon angioplasty in superficial femoral arteries
5.
go back to reference Bosch JL, Tetteroo E, Mali WP, Hunink MG (1998) Iliac arterial occlusive disease: cost–effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiology 208(3):641–648PubMed Bosch JL, Tetteroo E, Mali WP, Hunink MG (1998) Iliac arterial occlusive disease: cost–effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiology 208(3):641–648PubMed
Metadata
Title
Endovascular management of aorto-iliac occlusive disease
Author
Gerard J. O’Sullivan
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 3/2009
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-008-9397-3

Other articles of this Issue 3/2009

Abdominal Radiology 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine